• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eventide Healthcare & Life Sciences Fund

+ Add to Watchlist

ETCHX:US

16.18 USD 0.21 1.28%

As of 09:29:30 ET on 08/20/2014.

Snapshot for Eventide Healthcare & Life Sciences Fund (ETCHX)

Year To Date: +0.43% 3-Month: +12.13% 3-Year: - 52-Week Range: 13.97 - 19.71
1-Month: +4.12% 1-Year: +16.15% 5-Year: - Beta vs SPX: -

Mutual Fund Chart for ETCHX

No chart data available.
  • ETCHX:US 16.18
  • 1M
  • 1Y
Interactive ETCHX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETCHX

Eventide Healthcare & Life Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund will invest at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences industries.

Inception Date: 12-27-2012 Telephone: 1-866-447-4228
Managers: FINNY GEORGE KURUVILLA
Web Site: www.catalystmutualfunds.com

Fundamentals for ETCHX

NAV (on 2014-08-20) 16.18
Assets (M) (on 2014-08-20) 108.50
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for ETCHX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ETCHX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 1.00
Expense Ratio 2.43

Top Fund Holdings for ETCHX

Filing Date: 06/30/2014
Name Position Value % of Total
Agios Pharmaceuticals Inc 94,698 4,339,041 3.670%
Medivation Inc 41,568 3,204,033 2.710%
Bluebird Bio Inc 76,940 2,967,573 2.510%
Dyax Corp 302,964 2,908,458 2.460%
AtriCure Inc 152,451 2,802,051 2.370%
GW Pharmaceuticals PLC 25,015 2,683,821 2.270%
Salix Pharmaceuticals Ltd 21,758 2,683,821 2.270%
Veracyte Inc 154,693 2,648,352 2.240%
AbbVie Inc 46,923 2,648,352 2.240%
Supernus Pharmaceuticals Inc 240,779 2,636,529 2.230%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil